Sex: F
Vaccine: COVID19
Symptoms: Muscle tightness, Musculoskeletal discomfort, Pain in extremity, Pelvic pain, Vaccination site pain
Clinical narrative: started experiencing discomfort in her calvies and described it as a tightness; started experiencing discomfort in her calvies and described it as a tightness; feeling pain at the injection site; felt pain in her pelvic area and bones in her legs, discomfort in arm muscles.; felt pain in her pelvic area and bones in her legs, discomfort in arm muscles.; felt pain in her pelvic area and bones in her legs, discomfort in arm muscles.; felt pain in her pelvic area and bones in her legs, discomfort in arm muscles.; She has lingering pain in her knee caps, discomfort in joints; She has lingering pain in her knee caps, discomfort in joints; a slight headache; Arm pain; This is a spontaneous report from a contactable consumer. This female consumer (Patient reported for herself) that:  A 66-year-old female patient received first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: Unknown) via an unspecified route of administration, on unspecified date as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medication were not reported. On an unspecified date, the patient started to experience discomfort in her calvies and described it as a tightness. Four hour later the patient had feeling pain at the injection site. Patient woke up and felt pain in her pelvic area and bones in patient legs, discomfort in arm muscles. Patient had lingering pain in kneecaps and discomfort in joints. Patient stated that pain in her legs had gotten a tiny bit better. Patient also reported that she experienced a slight headache after receiving the vaccine. Patient called her doctor's office and spoke with the physicians assistant who told her that there was not a lot of information on the vaccine and also told that her she had 3 patients with severe side effects over 3 weeks later. The patient was concerned that she was having symptoms still 72 hours after the first dose when most people she spoke with do not even have a reaction after the first dose. Patient queried if this was "normal" or not. Patient filed a report. Patient raised concerned about whether or not to take second dose of the vaccine. Patient received the response that as noted in the fact sheet for recipients, patient should not get the Pfizer-BioNTech COVID-19 Vaccine if patient had a severe allergic reaction after a previous dose of the vaccine or if patient had a severe allergic reaction to any ingredient of the vaccine. The decision to receive the second dose for any other reason cannot be made by Pfizer. We refer patient to speak to your healthcare provider about the risks of the vaccine compared to the risks of potentially not being fully protected against COVID-19 infection. Patient healthcare provider knows your health situation and has access to information that can better help inform this decision. The outcome for the reported of arm pain was recovered on an unspecified date and was unknown for other reported events.  Follow-up attempts not completed; information about lot/batch number cannot be obtained. No further information expected.